ArticleGland surgery2026
Effect of thyrotropin suppression therapy on bone microarchitecture in postoperative patients with differentiated thyroid cancer.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: One of the main hazards of long-term subclinical hyperthyroidism is the induction and acceleration of osteoporosis. The aim of this study was to investigate the effect of postoperative thyrotropin (TSH) suppression therapy on bone microarchitecture in differentiated thyroid cancer (DTC). Methods: This is a cross-sectional study involving 67 adult patients with DTC after surgery. Among them, 35 patients were currently undergoing TSH suppression therapy. The remaining 32 patients currently had normal thyroid function, but had a prior history of TSH suppression therapy. By utilizing high-resolution peripheral quantitative computed tomography (HR-pQCT) to scan the distal radius and tibia, the three-dimensional structure of the skeleton was reconstructed and measurements of bone microarchitecture were obtained. Results: Compared with age- and gender-matched controls, the 35 patients with DTC under TSH suppression therapy had lower total volumetric bone mineral density and decreased cortical thickness at the distal radius. In the subgroup of 30 female patients, the total volumetric bone mineral density, cortical thickness, and trabecular thickness of distal radius were found to be lower than those of the control group. There were 15 postmenopausal women included in the study. Whether they were under TSH suppression therapy or their thyroid function returned to normal, they had lower cortical volumetric bone mineral density at the distal radius. Patients under TSH suppression therapy also had decreased cortical thickness at the distal radius, and lower cortical volumetric bone mineral density at the distal tibia. Conclusions: The subclinical hyperthyroidism caused by TSH suppression therapy may impact bone microarchitecture, especially in the cortical region at the distal radius.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.